These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19144446)
1. Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Song JW; Oh YM; Shim TS; Kim WS; Ryu JS; Choi CM Lung Cancer; 2009 Sep; 65(3):333-8. PubMed ID: 19144446 [TBL] [Abstract][Full Text] [Related]
2. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
3. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer. Lee JW; Lee SM; Lee HS; Kim YH; Bae WK Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551 [TBL] [Abstract][Full Text] [Related]
4. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Cheran SK; Herndon JE; Patz EF Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545 [TBL] [Abstract][Full Text] [Related]
5. Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT. Liu N; Ma L; Zhou W; Pang Q; Hu M; Shi F; Fu Z; Li M; Yang G; Yu J Eur J Radiol; 2010 Apr; 74(1):231-5. PubMed ID: 19285820 [TBL] [Abstract][Full Text] [Related]
6. The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer. Min JW; Um SW; Yim JJ; Yoo CG; Han SK; Shim YS; Kim YW J Korean Med Sci; 2009 Apr; 24(2):275-80. PubMed ID: 19399270 [TBL] [Abstract][Full Text] [Related]
7. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases? Sahin E; Zincirkeser S; Akcan AB; Elboga U J BUON; 2014; 19(1):291-6. PubMed ID: 24659678 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Al-Bulushi NK; Abouzied ME Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992 [TBL] [Abstract][Full Text] [Related]
9. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients. Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer]. Yang WF; Tan GZ; Fu Z; Yu JM Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335 [TBL] [Abstract][Full Text] [Related]
12. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
14. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Krüger S; Buck AK; Mottaghy FM; Hasenkamp E; Pauls S; Schumann C; Wibmer T; Merk T; Hombach V; Reske SN Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1807-12. PubMed ID: 19504092 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients]. Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients. Rodrigues M; Stark H; Rendl G; Rettenbacher L; Datz L; Studnicka M; Pirich C Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):62-8. PubMed ID: 26844431 [TBL] [Abstract][Full Text] [Related]
17. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Chakraborty D; Bhattacharya A; Mete UK; Mittal BR Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596 [TBL] [Abstract][Full Text] [Related]